Lucid Diagnostics Inc. financial data

Symbol
LUCD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
360 Madison Avenue, 25 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 132 % +14.3%
Quick Ratio 2.83 %
Debt-to-equity 202 % -27.5%
Return On Equity -460 % +12.2%
Return On Assets -152 % -10.1%
Operating Margin -1.06K % +46.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 90.8M shares +85%
Common Stock, Shares, Outstanding 63.1M shares +49%
Entity Public Float 14.6M USD +1.39%
Common Stock, Value, Issued 63K USD +50%
Weighted Average Number of Shares Outstanding, Basic 50.5M shares +21%
Weighted Average Number of Shares Outstanding, Diluted 50.5M shares +21%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.35M USD +79%
Revenue from Contract with Customer, Excluding Assessed Tax 4.35M USD +79%
Research and Development Expense 5.99M USD -17.4%
Selling and Marketing Expense 16.5M USD +0.36%
General and Administrative Expense 20.2M USD +4.69%
Operating Income (Loss) -46.1M USD +5.01%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -45.5M USD +13.6%
Net Income (Loss) Attributable to Parent -45.5M USD +13.6%
Earnings Per Share, Basic -1.05 USD/shares +16.7%
Earnings Per Share, Diluted -1.05 USD/shares +16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22.4M USD +18.3%
Accounts Receivable, after Allowance for Credit Loss, Current 45K USD 0%
Inventory, Net 341K USD +22.7%
Assets, Current 25.1M USD +13.9%
Property, Plant and Equipment, Net 1.06M USD -20.4%
Operating Lease, Right-of-Use Asset 2.64M USD +102%
Intangible Assets, Net (Excluding Goodwill) 736K USD -48.3%
Other Assets, Noncurrent 1.13M USD 0%
Assets 30.7M USD +12.6%
Accounts Payable, Current 1.24M USD +8.29%
Employee-related Liabilities, Current 1.48M USD +25.6%
Liabilities, Current 23.5M USD -19.9%
Operating Lease, Liability, Noncurrent 1.8M USD +805%
Liabilities 25.3M USD -14.4%
Retained Earnings (Accumulated Deficit) -204M USD -35.2%
Stockholders' Equity Attributable to Parent 5.39M USD
Liabilities and Equity 30.7M USD +12.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.6M USD -77.1%
Net Cash Provided by (Used in) Financing Activities 18.5M USD -23.4%
Net Cash Provided by (Used in) Investing Activities -37K USD -118%
Common Stock, Shares Authorized 300M shares +50%
Common Stock, Shares, Issued 63.1M shares +49%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.87M USD -65.6%
Deferred Tax Assets, Valuation Allowance 52.4M USD +24.2%
Deferred Tax Assets, Gross 53.1M USD +25.9%
Operating Lease, Liability 2.65M USD +103%
Payments to Acquire Property, Plant, and Equipment 17K USD -88.5%
Lessee, Operating Lease, Liability, to be Paid 2.96M USD +115%
Property, Plant and Equipment, Gross 2.21M USD +5.14%
Operating Lease, Liability, Current 854K USD -22.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 979K USD +671%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.03M USD -11.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 309K USD +341%
Lessee, Operating Lease, Liability, to be Paid, Year Three 940K USD +1392%
Deferred Tax Assets, Operating Loss Carryforwards 39.5M USD +35.8%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 19K USD -20.8%
Operating Lease, Payments 305K USD +7.02%
Additional Paid in Capital 155M USD +19.2%
Amortization of Intangible Assets 688K USD -66%
Depreciation, Depletion and Amortization 501K USD -18.1%
Deferred Tax Assets, Net of Valuation Allowance 52.4M USD +24.2%
Share-based Payment Arrangement, Expense 4.53M USD -33.5%
Interest Expense 26K USD -93.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%